Analysis

  • No risk, no reward – outsourcing the supply chain

    Although pharmaceutical companies rely heavily on contractors, the industry is still new to the world of outsourcing. Risk management strategies across parts of the pharmaceutical supply chain remain surprisingly unsophisticated....

  • Take a load off: the age of cloud computing

    Excessive, unmanageable data may be to blame for low productivity rates in the drug industry. Sarah Blackman looks at how cloud computing can streamline this data to make information more...

  • Taking aim with nanotechnology

    One of the key challenges of drug delivery is ensuring the right dose reaches the target without damaging healthy cells. Richard Moore of the Institute of Nanotechnology and inventor, entrepreneur...

  • Carpooling for Cargo

    One in four goods vehicles in the EU are running empty, creating substantial supply chain inefficiencies. Elly Earls catches up with UCB's Marc Mostinckx and TRI-VIZOR's Alex Van Breedam to...

  • The sustainable supply chain

    In 2006, 14 pharma companies came together to monitor standards in the supply chain, especially in the developing world. Chris Lo speaks to Pharmaceutical Supply Chain Initiative organiser Mark Little...

  • The patent cliff: rise of the generics

    Twenty blockbuster drugs are set to go off patent within the next few years, leading big pharma into a new era of R&D. Elisabeth Fischer finds out how major pharmaceutical...

Close
Close
Close

Go Top